Simparica Trio is a drug owned by ZOETIS INC. It is protected by 4 US drug patents filed from 2032 to 2041. All patents are active. Details of Simparica Trio’s patents and their expiration are given below.
Exclusivity Information
Simparica Trio holds 1 exclusivity out of which 1 has expired. Details of Simparica Trio's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Dec 23, 2024 |
About Simparica Trio
Simparica Trio is a drug
owned by ZOETIS INC.
Simparica Trio uses
Moxidectin, Pyrantel Pamoate, Sarolaner as the active
ingredients.
Active Ingredient:
Simparica Trio uses
Moxidectin,
Pyrantel Pamoate, Sarolaner
as the active ingredients.
Check out other Drugs and Companies using
Moxidectin, Pyrantel Pamoate, Sarolaner ingredient.